Ivey Business School (Canada)
-
Tetra Bio-Pharma: Brand Building in the Cannabinoid Pharmaceutical Market
Jake Girard; Peter Voyer; Gerry KerrCase IVEY-9B20A003-EEntrepreneurship, MarketingTetra Bio-Pharma (Tetra) was a new firm operating in a murky but promising industry—cannabinoid-derived pharmaceutical products. But, the firm had been so involved in navigating drug development and approval processes that it had lost track of its identity. The firm did not define itself initially, and with its rapid growth, shifting strategies, evolving competencies, and plethora of alliances, Tetra needed a stronger focus. Adding to the turmoil...Starting at €8.20
-
Lululemon: Stay Public or Go Private?
W. Glenn Rowe; Maria SemenovaCase IVEY-9B15M033-EStrategyAfter having virtually created the yoga-wear segment more than a decade earlier and having become a stock-market darling, Lululemon Athletica finds itself at a critical point in its development. After a series of missteps and a first-quarter profit drop of 60 per cent, the yoga-wear retailer’s founder, Chip Wilson, prepares to go into battle, meeting with banks and private equity firms to mount a buyout and take the company private. Similar to ot...Starting at €8.20
-
Growth and Transition at Onex Corporation
W. Glenn Rowe; Rod E. White; Maria SemenovaCase IVEY-9B16M123-EStrategyOver its 30-year history, Onex Corporation, a Canadian investment firm, had derived much of its success from the private equity sector. It did so by acquiring attractive portfolio companies, adding value to them by improving their financial and operational performance, and then selling them several years later at an attractive return. However, given the market conditions in 2015, Onex Corporation faced difficulty in successfully acquiring target ...Starting at €8.20